These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 31332856

  • 1. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K, Miyazaki S, Ishikawa E, Mukai M, Aoyama D, Nodera M, Kaseno K, Tada H.
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract] [Full Text] [Related]

  • 2. Implantable Cardioverter-Defibrillators and Wearable Defibrillators: Guidelines and Updates.
    Mathuria N.
    Tex Heart Inst J; 2020 Feb; 47(1):51-52. PubMed ID: 32148457
    [No Abstract] [Full Text] [Related]

  • 3. Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator.
    Adduci C, Spadoni L, Palano F, Francia P.
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1373-1374. PubMed ID: 31165543
    [No Abstract] [Full Text] [Related]

  • 4. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S, Aktas M, Mutluer FO, Guler TE, Dervis E, Argan O, Celikyurt U, Agir A, Vural A.
    Acta Cardiol; 2019 Jun; 74(3):246-251. PubMed ID: 30058473
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C, Atienza F, Strasberg B, Arenal Á, Codner P, González-Torrecilla E, Datino T, Percal T, Almendral J, Ortiz M, Martins R, Martinez-Alzamora N, Fernandez Aviles F.
    Cardiol J; 2015 Jun; 22(3):253-9. PubMed ID: 25179316
    [Abstract] [Full Text] [Related]

  • 6. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY, Yam N, Lun KS, Chen RH, Au TW, Yung TC.
    Europace; 2018 Sep 01; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract] [Full Text] [Related]

  • 7. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD, Hale L, Arteaga C, Xu M, Keebler M, Schlendorf K, Danter M, Shah A, Lindenfeld J, Ellis CR.
    J Am Heart Assoc; 2018 Feb 23; 7(5):. PubMed ID: 29475875
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic study: its predictive value for ventricular arrhythmias.
    Gold DR, Catanzaro JN, Makaryus JN, Waldman C, Sauer WH, Sison C, Makaryus AN, Altman E, Jadonath R, Beldner S.
    Tex Heart Inst J; 2010 Feb 23; 37(3):291-6. PubMed ID: 20548804
    [Abstract] [Full Text] [Related]

  • 9. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W.
    Cardiol J; 2009 Feb 23; 16(5):391-3. PubMed ID: 19753515
    [No Abstract] [Full Text] [Related]

  • 10. Multiple ICD shocks in a patient with dilated cardiomyopathy: What is the mechanism?
    Fontenla A, López-Gil M, Rodríguez Muñoz D, Díez de Las Heras D, Arribas F.
    J Cardiovasc Electrophysiol; 2019 May 23; 30(5):781-784. PubMed ID: 30688386
    [Abstract] [Full Text] [Related]

  • 11. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond.
    van Dijk VF, Boersma LV.
    Trends Cardiovasc Med; 2020 Aug 23; 30(6):378-384. PubMed ID: 31610949
    [Abstract] [Full Text] [Related]

  • 12. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M, Proclemer A, Boriani G, Landolina M, Locati E, Rordorf R, Daleffe E, Ricci RP, Catanzariti D, Tomasi L, Gulizia M, Baccillieri MS, Molon G, Gasparini M, ClinicalService Cardiological Centres.
    Europace; 2016 Sep 23; 18(9):1391-8. PubMed ID: 26826135
    [Abstract] [Full Text] [Related]

  • 13. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA, Deeprasertkul P, Nannapaneni N, Carayannopoulos GN.
    J Cardiovasc Electrophysiol; 2015 Feb 23; 26(2):228-9. PubMed ID: 25354719
    [No Abstract] [Full Text] [Related]

  • 14. Narrow QRS tachycardia in a patient with old infarction. What Is the mechanism?
    Banavalikar B, Shenthar J.
    J Cardiovasc Electrophysiol; 2017 Nov 23; 28(11):1357-1360. PubMed ID: 28841250
    [No Abstract] [Full Text] [Related]

  • 15. Augmented QRS notching and macroscopic T-wave alternans preceding polymorphic ventricular tachycardia in a patient with electrical storm.
    Minatoguchi S, Takasugi N, Kubota T, Ushikoshi H, Nishigaki K, Minatoguchi S.
    Europace; 2017 Apr 01; 19(4):643. PubMed ID: 28339622
    [No Abstract] [Full Text] [Related]

  • 16. Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Kanagasundram AN, John RM, Stevenson WG.
    Circulation; 2018 May 01; 137(18):1885-1887. PubMed ID: 29712693
    [No Abstract] [Full Text] [Related]

  • 17. Effect of ICD Therapies on Mortality in the OMNI Trial.
    Sun S, Johnson J, Degroot P, Brown ML, Obel O.
    J Cardiovasc Electrophysiol; 2016 Feb 01; 27(2):192-9. PubMed ID: 26501695
    [Abstract] [Full Text] [Related]

  • 18. Idiopathic ventricular fibrillation triggered by premature atrial complexes.
    Iizuka T, Kaneko Y, Nakajima T, Kurabayashi M.
    J Cardiovasc Electrophysiol; 2015 Jan 01; 26(1):98-100. PubMed ID: 25216017
    [No Abstract] [Full Text] [Related]

  • 19. Pacemapping guided by defibrillator electrograms for ventricular tachycardia ablation in a patient with ARVD/C.
    Fontenla A, Lozano Á, López-Gil M, Arribas F.
    J Cardiovasc Electrophysiol; 2018 Feb 01; 29(2):336. PubMed ID: 29024127
    [No Abstract] [Full Text] [Related]

  • 20. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P, Adduci C, Palano F, Semprini L, Serdoz A, Montesanti D, Santini D, Musumeci B, Salvati A, Volpe M, Autore C.
    J Cardiovasc Electrophysiol; 2015 Aug 01; 26(8):893-899. PubMed ID: 25996259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.